Ardian, Sagemount, Eir, Thoma Bravo back life sciences software; 1315 Capital eyes value creation potential in Argonaut’s diagnostics division
AI and regulatory complexity are driving demand for life sciences software, which in turn has attracted private equity; 1315 Capital closes a carve-out deal with a portfolio company of Telegraph Hill Partners and New Vale Capital. The post Ardian, Sagemount, Eir, Thoma Bravo back life sciences software; 1315 Capital eyes value creation potential in Argonaut’s diagnostics division appeared first…
We haven't written up this one. PE Hub has the full story — the link below goes straight to it.
